The bilirubin meters market has seen considerable growth due to a variety of factors.
• The bilirubin meters market has expanded significantly in recent years. It will grow from $0.53 billion in 2024 to $0.57 billion in 2025, at a CAGR of 7.5%.
The growth during the past period has been fueled by rising awareness, supportive government policies, greater preference for home healthcare, an aging population, and economic growth in emerging markets.
The bilirubin meters market is expected to maintain its strong growth trajectory in upcoming years.
• The bilirubin meters market is projected to grow to $0.76 billion by 2029, at a CAGR of 7.5%.
Factors driving this growth include an increase in neonatal jaundice cases, higher healthcare expenditure, growth in diagnostic centers, favorable reimbursement policies, and the rise of medical tourism. Major trends include innovations in bilirubin meter technology, hospital infrastructure development, demand for point-of-care devices, increased R&D investments, and partnerships between manufacturers and healthcare providers.
The rising prevalence of liver diseases is expected to boost the growth of the bilirubin meter market. Liver diseases are on the rise due to factors like obesity, alcohol use, and viral infections. Bilirubin meters are crucial for non-invasive measurement of bilirubin levels in patients with liver dysfunction. The Office for Health Improvement & Disparities reported 5,776 premature deaths from alcoholic liver disease in England in 2022. Therefore, the increasing number of liver disease cases is driving the growth of the bilirubin meter market.
The bilirubin meters market covered in this report is segmented –
1) By Product: Transcutaneous Devices, Benchtop
2) By Age Group: Neonates, Adults
3) By Indication: Jaundice, Hepatitis, Other Indications
4) By Application: Hospital, Medical Center, Other Applications
Subsegments:
1) By Transcutaneous Devices: Handheld Transcutaneous Bilirubin Meters, Portable Transcutaneous Bilirubin Meters
2) By Benchtop: Single-Channel Benchtop Bilirubin Meters, Multi-Channel Benchtop Bilirubin Meters
Companies in the bilirubin meters market are innovating with non-invasive bilirubin meters for quick and convenient monitoring. In November 2022, Yishan Medical, a China-based company, launched the Intelligent Neonatal Transdermal Jaundice Instrument. This portable, easy-to-operate device uses light-based technology to measure bilirubin levels without blood samples, making it ideal for neonatal jaundice care in medical institutions.
Major companies operating in the bilirubin meters market are:
• Hoffmann-La Roche Ltd.
• Abbott Laboratories
• Siemens Healthineers AG
• Koninklijke Philips N.V.
• GE Healthcare
• Shenzhen Mindray Bio-Medical Electronics Co. Ltd.
• PerkinElmer
• Drägerwerk AG Co.
• Sysmex Corporation
• Konica Minolta Business Solutions Inc.
• Masimo Corp.
• Beckman Coulter Inc.
• Nova Biomedical
• Loewenstein Medical UK Ltd.
• Ningbo David Medical Device Co. Ltd.
• Reichert Inc.
• A. Menarini Diagnostics Srl
• Mennen Co.
• Delta Medical International Ltd.
• AVI Healthcare Pvt Ltd.
• Olidef
• Micro Lab Instruments
• Aegis Medical Innovations Inc.
• Medi Waves Inc.
• Ginevri Srl
North America was the largest region in the bilirubin meters market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the bilirubin meters market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.